greenlifescience

May 29, 2026 The biotechnology and pharmaceutical sector continues to advance through a combination of large-scale strategic investment, rapid progress in advanced therapeutic modalities, and mounting pressure to demonstrate durable clinical and commercial outcomes. Growth remains particularly strong across cell therapy, metabolic disease, neuroscience, gene therapy, and infectious disease, while artificial intelligence and industrial-scale manufacturing […]

May 15, 2026 This week’s developments across the biotechnology and pharmaceutical sector highlight an industry being shaped by renewed investor confidence, expanding therapeutic innovation, and increasingly complex global operating conditions. Momentum continued to build across areas such as oncology, metabolic disease, nephrology, and radiopharmaceuticals, while broader economic and geopolitical pressures continued to influence supply chains,

May 8, 2026 This week’s developments across the biotechnology and pharmaceutical sector reflect a landscape being shaped simultaneously by scientific advancement, capital deployment, and increasing external disruption. While innovation continues to accelerate across oncology, obesity, and rare disease, companies are also navigating a more complex backdrop defined by geopolitical instability, shifting policy priorities, and intensifying

May 1, 2026 This week, we look at a broad and evolving mix of strategic transactions, clinical progress, capital flows, and policy developments shaping the global biotechnology and pharmaceutical landscape. Momentum continues to build across high-growth therapeutic areas such as obesity, neuroscience, and immunology, while external forces, including pricing reform, global health funding constraints, and

Clinical Research Hiring Trends 2026: Site-Level Demand, PI Scarcity & Market Growth By Daniel Bishop, Clinical Research Recruitment Specialist April 16th 2026 Clinical Research Hiring Trends Heading into 2026 Our internal placement data highlights a clear structural trend within the clinical research market. Demand remains heavily weighted toward clinical and site-level functions, with hiring volumes

CRO Hiring Trends 2026: BD Attrition, Salaries & Market Demand By Robert Green, CRO Commercial Headhunter April 16th 2026 CRO Hiring Trends Heading into 2026 Our internal data from 2025 highlights a clear shift in the CRO market – particularly within business development hiring and attrition trends. Most notably, we saw 21% movement in 2025,

What Separates a £5M BD Manager from a £50M CRO Revenue Leader By Robert Green, CRO Commercial Headhunter April 15th 2026 One of the most important inflexion points in any scaling CRO is the shift from tactical selling to becoming a CRO revenue leader. On the surface, the roles can look similar. But the difference

CRO Revenue Stalling? It’s Usually Not a Sales Problem By Robert Green, CRO Commercial Headhunter April 15th 2026 Over the past 12–18 months, I’ve had repeated conversations with CRO CEOs hearing the same thing: “We have strong BD people.”“They’re active.”“They’re busy.”“But growth has plateaued.” When CRO revenue stalls, the default assumption is that it’s a